Park YG - Search Results

1

Complement System and Potential Therapeutics in Age-Related Macular Degeneration.

Park YG, Park YS, Kim IB. Park YG, et al. Among authors: park ys. Int J Mol Sci. 2021 Jun 25;22(13):6851. doi: 10.3390/ijms22136851. Int J Mol Sci. 2021. PMID: 34202223 Free PMC article. Review.

2

New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration.

Park YG, Rhu HW, Kang S, Roh YJ. Park YG, et al. J Ophthalmol. 2012;2012:637316. doi: 10.1155/2012/637316. Epub 2012 Feb 9. J Ophthalmol. 2012. PMID: 22496964 Free PMC article.

3

VISUAL PROGNOSIS AFTER PNEUMATIC DISPLACEMENT OF SUBMACULAR HEMORRHAGE ACCORDING TO AGE-RELATED MACULAR DEGENERATION SUBTYPES.

Lee K, Park YG, Park YH. Lee K, et al. Among authors: park yh, park yg. Retina. 2020 Dec;40(12):2304-2311. doi: 10.1097/IAE.0000000000002762. Retina. 2020. PMID: 31985556

4

Electroretinography and retinal microvascular changes in type 2 diabetes.

Kim M, Kim RY, Park W, Park YG, Kim IB, Park YH. Kim M, et al. Among authors: park yh, park yg, park w. Acta Ophthalmol. 2020 Nov;98(7):e807-e813. doi: 10.1111/aos.14421. Epub 2020 Apr 4. Acta Ophthalmol. 2020. PMID: 32246578 Free article.

5

One-Year Functional and Anatomical Outcomes After Selective Retina Therapy With Real-Time Feedback-Controlled Dosimetry in Patients With Intermediate Age-Related Macular Degeneration: A Pilot Study.

Kim M, Park YG, Roh YJ. Kim M, et al. Among authors: park yg. Lasers Surg Med. 2021 Apr;53(4):499-513. doi: 10.1002/lsm.23305. Epub 2020 Aug 5. Lasers Surg Med. 2021. PMID: 32757324

6

One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages.

Park YG, Roh YJ. Park YG, et al. BMC Ophthalmol. 2015 Dec 21;15:182. doi: 10.1186/s12886-015-0172-2. BMC Ophthalmol. 2015. PMID: 26691185 Free PMC article.

7

Safety and efficacy of selective retina therapy (SRT) for the treatment of diabetic macular edema in Korean patients.

Park YG, Kim JR, Kang S, Seifert E, Theisen-Kunde D, Brinkmann R, Roh YJ. Park YG, et al. Graefes Arch Clin Exp Ophthalmol. 2016 Sep;254(9):1703-13. doi: 10.1007/s00417-015-3262-1. Epub 2016 Jan 23. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 26803489 Clinical Trial.

8

The efficacy of selective retina therapy for diabetic macular edema based on pretreatment central foveal thickness.

Kim M, Park YG, Jeon SH, Choi SY, Roh YJ. Kim M, et al. Among authors: park yg. Lasers Med Sci. 2020 Oct;35(8):1781-1790. doi: 10.1007/s10103-020-02984-6. Epub 2020 Feb 24. Lasers Med Sci. 2020. PMID: 32095921

9

Quantitative Analysis of Retinal Microvascular Perfusion and Novel Biomarkers of the Treatment Response in Diabetic Macular Edema.

Park YG, Park YH. Park YG, et al. Among authors: park yh. J Diabetes Res. 2020 Nov 16;2020:2132037. doi: 10.1155/2020/2132037. eCollection 2020. J Diabetes Res. 2020. PMID: 33282960 Free PMC article.

10

Clinical course after the onset of choroidal neovascularization in eyes with central serous chorioretinopathy.

Kim RY, Ma GJ, Park WK, Kim M, Park YG, Park YH. Kim RY, et al. Among authors: park yh, park yg, park wk. Medicine (Baltimore). 2021 Aug 27;100(34):e26980. doi: 10.1097/MD.0000000000026980. Medicine (Baltimore). 2021. PMID: 34449466 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

915 results

Search Page

Filters